What Is Cagrilintide?

Cagrilintide is a long-acting amylin analogue currently under investigation in preclinical and clinical research settings. Derived from the naturally occurring hormone amylin, it has been engineered with structural modifications to extend its half-life and improve binding characteristics. Researchers are studying its potential roles in metabolic signalling pathways, with an emphasis on energy homeostasis and appetite-related mechanisms in controlled laboratory environments.

As a research compound, cagrilintide is supplied to qualified investigators for use in compliance with institutional and regulatory guidelines. It is not approved for human therapeutic use by Health Canada or any equivalent regulatory authority.

Mechanism of Action — Research Context

In preclinical research models, cagrilintide is understood to act as an agonist at amylin receptors, which are distributed in regions of the central nervous system associated with satiety regulation. Amylin receptors are formed by the co-expression of calcitonin receptors with receptor activity-modifying proteins (RAMPs), and activation of these complexes has been studied in relation to metabolic signalling cascades in animal models.

The structural modifications incorporated into cagrilintide — including fatty acid side chain acylation — are designed to improve plasma protein binding and extend circulating half-life compared to native amylin. These properties make it a useful tool compound for sustained-exposure studies in research settings. All mechanistic data referenced here derives from preclinical or early-phase investigational sources.

Research Applications

• Metabolic research: Cagrilintide has been investigated in models examining energy balance, body weight regulation, and adipose metabolism in preclinical settings.
• Combination receptor studies: Researchers have examined cagrilintide in combination with GLP-1 receptor agonists in dual-agonist paradigms, exploring synergistic signalling in rodent and non-human primate models.
• Pharmacokinetics: The extended half-life properties of cagrilintide make it suitable for studies requiring sustained compound exposure over multi-day timeframes without repeated dosing.
• Central nervous system research: Amylin receptor expression in hypothalamic regions has prompted interest in studying cagrilintide in neuropeptide signalling research.

This compound is used strictly in laboratory and preclinical research contexts. Any application outside controlled research protocols requires appropriate ethical and regulatory approval.

View Cagrilintide 5mg — Research Grade

Storage & Handling

Proper storage is essential to preserve peptide integrity. Research-grade cagrilintide should be handled in accordance with standard peptide laboratory protocols. General guidance for lyophilised peptide powders includes:

• Store lyophilised powder at −20°C, protected from light and moisture
• Reconstitute using sterile bacteriostatic water or an appropriate buffer as specified in your research protocol
• Once reconstituted, store at 4°C and use within the timeframe established by your laboratory’s SOP
• Avoid repeated freeze-thaw cycles, which may degrade compound integrity
• Label and track all vials with lot number and preparation date

For comprehensive storage guidance, see our Peptide Storage Guide. Purity and handling standards are described on our Quality & Purity page.

Related Research

Cagrilintide has been studied in investigational contexts alongside compounds such as semaglutide in dual-agonist combination trials. The broader amylin analogue class, which includes pramlintide (an FDA-approved drug), provides mechanistic context for understanding how synthetic amylin derivatives interact with receptor systems in research models. Researchers interested in metabolic peptide research may also review literature on GLP-1 receptor biology and energy homeostasis neuropeptides.

Explore our full Research Hub for additional compound overviews and research context. All TrueCanPeptides compounds are tested for purity — see our Quality & Purity standards.

⚠️ Research Use Only: All content on this page is intended strictly for educational and informational purposes. This compound is not approved by Health Canada or any regulatory agency for human therapeutic use. TrueCanPeptides supplies research-grade compounds to qualified researchers only. This is not medical advice. Do not use any information here for self-administration, diagnosis, or treatment. Consult a licensed healthcare professional for any medical concerns.

See also: What is Semaglutide?